← CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | — | — | — | — | — | $492.6m | $480.4m | $25.3m | ($142.2m) | |
| Net Income (Loss) Attributable to Parent | $154.8m | $123.4m | $226.4m | $252.0m | $364.3m | $391.0m | $486.2m | $474.6m | $22.2m | ($144.3m) | |
| Net Income (Loss) Available to Common Stockholders, Basic | $156.4m | $125.4m | $228.7m | $254.1m | $365.3m | $398.8m | $492.6m | $480.4m | $10.3m | ($144.3m) | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $156.4m | $125.4m | $228.7m | $254.1m | $365.3m | $398.8m | $492.6m | $480.4m | $25.3m | ($142.2m) | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $156.1m | $125.6m | $227.2m | $254.1m | $365.3m | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $280k | ($137k) | $1.5m | $0 | $0 | — | — | — | — | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.6m | $2.1m | $2.4m | $2.0m | $1.0m | $7.9m | $6.4m | $5.7m | $3.1m | $2.2m | |
| Depreciation, Depletion and Amortization | $126.7m | $131.2m | $161.8m | $198.1m | $234.9m | $265.5m | $303.9m | $314.1m | $361.7m | $403.3m | |
| Amortization of Debt Issuance Costs and Discounts | $2.8m | — | — | — | — | — | — | — | — | — | |
| Amortization of Intangible Assets | $41.7m | $41.4m | $64.8m | $89.5m | $111.9m | $124.9m | $146.6m | $137.4m | $138.5m | $179.1m | |
| Depreciation | $85.0m | $89.8m | $96.9m | $108.6m | $123.0m | $140.7m | $157.3m | $176.7m | $190.2m | $177.6m | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $303.9m | $314.1m | $361.7m | $403.3m | |
| Deferred Income Tax Expense (Benefit) | $3.2m | $28.0m | ($10.3m) | ($21.5m) | $1.6m | ($20.3m) | ($33.1m) | ($51.3m) | ($67.2m) | ($75.4m) | |
| Deferred Income Tax | — | — | — | — | — | — | ($35.9m) | ($50.9m) | ($67.4m) | ($75.3m) | |
| Deferred Tax | — | — | — | — | — | — | ($35.9m) | ($50.9m) | ($67.4m) | ($75.3m) | |
| Share-based Payment Arrangement, Noncash Expense | $43.6m | $44.0m | $47.3m | $57.3m | $56.3m | $71.5m | $73.6m | $72.0m | $69.9m | $71.1m | |
| Share-based Payment Arrangement, Expense | $43.6m | $44.0m | $47.3m | $57.3m | $56.3m | $71.5m | $73.6m | $72.0m | $69.9m | $71.1m | |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | — | — | — | — | — | — | $17.4m | |
| Goodwill, Impairment Loss | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $215.0m | $165.0m | |
| Impairment of Intangible Assets, Finite-lived | $1.9m | — | — | — | — | — | — | — | — | $211.0m | |
| Asset Impairment Charge | — | — | — | — | — | — | $11.8m | $48.2m | $313.8m | $436.5m | |
| Gain (Loss) on Disposition of Business | — | — | — | — | — | $25.0m | $123.4m | ($961k) | ($659k) | $3.4m | |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | — | ($30.0m) | ($4.1m) | ($4.0m) | — | — | |
| Income Tax Expense (Benefit) | $66.8m | $171.4m | $54.5m | $50.0m | $81.8m | $81.9m | $130.4m | $100.9m | $67.8m | $42.7m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $126.3m | $107.0m | |
| Other Nonoperating Income (Expense) | $11.9m | $38.5m | $13.3m | $12.3m | $100.0m | ($35.9m) | $30.5m | $95.5m | ($16.5m) | ($22.6m) | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | — | $26.8m | ($97.8m) | $12.9m | $24.9m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $52.8m | $48.3m | $21.2m | $8.3m | $85.6m | $26.6m | $150.6m | $33.4m | ($21.6m) | ($35.7m) | |
| Increase (Decrease) in Inventories | $4.0m | $17.8m | $13.3m | $21.4m | $18.4m | $25.2m | $78.5m | $62.3m | ($16.8m) | $48.8m | |
| Increase (Decrease) in Accounts Payable | $22.1m | $34k | ($12.7m) | $29.8m | $748k | $44.9m | ($2.7m) | ($20.4m) | ($14.3m) | $2.9m | |
| Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | — | $10.6m | $0 | $0 | — | — | — | — | — | — | |
| Goodwill | $787.5m | $804.9m | $1.2b | $1.5b | $1.8b | $2.7b | $2.8b | $3.1b | $2.8b | $2.8b | |
| Inventory Write-down | — | — | — | — | — | — | — | — | $47.0m | $12.4m | |
| Investment Income, Interest | $1.3m | $690k | $812k | $1.5m | $834k | $652k | $780k | $5.2m | $8.6m | $4.9m | |
| Payments of Financing Costs | — | — | $18.3m | $6.6m | $0 | $38.3m | $0 | $0 | — | — | |
| Proceeds from Stock Options Exercised | $23.2m | $38.9m | $37.7m | $34.5m | $46.6m | $45.7m | $25.1m | $25.6m | $23.9m | $714k | |
| Beginning Cash Position | — | — | — | — | — | — | $246.3m | $241.2m | $284.5m | $205.6m | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | ($42.4m) | ($85.5m) | ($550.9m) | ($536.7m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($607.9m) | ($563.2m) | ($245.1m) | ($209.3m) | |
| Change In Account Payable | — | — | — | — | — | — | ($2.7m) | ($20.4m) | ($14.3m) | $2.9m | |
| Change In Accrued Expense | — | — | — | — | — | — | ($42.2m) | $12.4m | ($27.6m) | $79.3m | |
| Change In Inventory | — | — | — | — | — | — | ($78.5m) | ($62.3m) | $16.8m | ($48.8m) | |
| Change In Other Working Capital | — | — | — | — | — | — | $121.4m | $1.3m | ($26.9m) | ($55.1m) | |
| Change In Payable | — | — | — | — | — | — | ($2.7m) | ($20.4m) | ($14.3m) | $2.9m | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | ($44.8m) | ($8.0m) | ($41.9m) | $82.2m | |
| Change In Receivables | — | — | — | — | — | — | ($150.6m) | ($33.4m) | $21.6m | $35.7m | |
| Change In Working Capital | — | — | — | — | — | — | ($152.6m) | ($102.4m) | ($30.3m) | $14.1m | |
| Changes In Cash | — | — | — | — | — | — | ($30.7m) | $35.2m | ($61.4m) | ($8.4m) | |
| End Cash Position | — | — | — | — | — | — | $241.2m | $284.5m | $205.6m | $216.0m | |
| Financing Cash Flow | — | — | — | — | — | — | ($42.4m) | ($85.5m) | ($550.9m) | ($536.7m) | |
| Free Cash Flow | — | — | — | — | — | — | $294.9m | $365.4m | $501.6m | $518.5m | |
| Gain Loss On Sale Of Business | — | — | — | — | — | — | ($123.4m) | $961k | $659k | ($3.4m) | |
| Investing Cash Flow | — | — | — | — | — | — | ($607.9m) | ($563.2m) | ($245.1m) | ($209.3m) | |
| Net Business Purchase And Sale | — | — | — | — | — | — | ($120.1m) | ($194.8m) | ($5.5m) | $17.4m | |
| Operating Gains Losses | — | — | — | — | — | — | ($96.6m) | ($96.9m) | $13.6m | $21.5m | |
| Other Non Cash Items | — | — | — | — | — | — | $16.1m | $1.1m | $33.3m | $2.5m | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | — | $25.1m | $25.6m | $23.9m | $714k | |
| Provisionand Write Offof Assets | — | — | — | — | — | — | $6.7m | $18.2m | $14.8m | $6.1m | |
| Purchase Of Business | — | — | — | — | — | — | ($283.4m) | ($194.8m) | ($5.5m) | $0 | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | ($38.7m) | ($24.2m) | ($119.2m) | ($360.7m) | |
| Sale Of Business | — | — | — | — | — | — | $163.3m | $0 | $0 | $17.4m | |
| Stock Based Compensation | — | — | — | — | — | — | $73.6m | $72.0m | $69.9m | $71.1m | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | — | $0 | $0 | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $300.4m | $318.1m | $441.1m | $480.9m | $546.6m | $760.8m | $619.6m | $683.9m | $734.6m | $737.6m | |
| Cash flows from investing activities: | |||||||||||
| Capital Expenditure | — | — | — | — | — | — | ($324.7m) | ($318.5m) | ($233.0m) | ($219.2m) | |
| Capital Expenditure Reported | $55.3m | $82.4m | $140.1m | $140.5m | $166.6m | $228.8m | ($324.7m) | ($318.5m) | ($233.0m) | ($219.2m) | |
| Payments to Acquire Businesses, Net of Cash Acquired | $648.5m | $25.0m | $824.9m | $515.7m | $418.6m | $1.3b | $283.4m | $194.8m | $5.5m | $0 | |
| Payments to Acquire Investments | — | $46.2m | $25.1m | $22.3m | $26.7m | $45.6m | $158.3m | $54.2m | $52.9m | $20.1m | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | ($153.7m) | ($47.5m) | ($11.2m) | ($11.0m) | |
| Purchase Of Investment | — | — | — | — | — | — | ($158.3m) | ($54.2m) | ($52.9m) | ($20.1m) | |
| Sale Of Investment | — | — | — | — | — | — | $4.5m | $6.7m | $41.7m | $9.1m | |
| Payments for (Proceeds from) Other Investing Activities | ($3.7m) | $516k | $805k | $3.9m | $1.1m | ($264k) | $9.3m | $2.3m | ($4.5m) | ($3.4m) | |
| Net Other Investing Changes | — | — | — | — | — | — | ($9.3m) | ($2.3m) | $4.5m | $3.4m | |
| Net Cash Provided by (Used in) Investing Activities | ($686.4m) | ($72.6m) | ($955.0m) | ($681.5m) | ($601.5m) | ($1.4b) | ($607.9m) | ($563.2m) | ($245.1m) | ($209.3m) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Long-term Debt | $1.0b | $236.9m | $2.8b | $3.4b | $2.2b | $7.0b | $3.0b | $776.4m | $1.1b | $1.2b | |
| Issuance Of Debt | — | — | — | — | — | — | $3.0b | $776.4m | $1.1b | $1.2b | |
| Long Term Debt Issuance | — | — | — | — | — | — | $3.0b | $776.4m | $1.1b | $1.2b | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | $19.8m | ($75.3m) | ($412.2m) | ($121.8m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | $19.8m | ($75.3m) | ($412.2m) | ($121.8m) | |
| Long Term Debt Payments | — | — | — | — | — | — | ($2.9b) | ($851.7m) | ($1.5b) | ($1.3b) | |
| Repayment Of Debt | — | — | — | — | — | — | ($2.9b) | ($851.7m) | ($1.5b) | ($1.3b) | |
| Net Common Stock Issuance | — | — | — | — | — | — | ($38.7m) | ($24.2m) | ($119.2m) | ($360.7m) | |
| Payments for Repurchase of Common Stock | $12.3m | $106.9m | $13.8m | $18.1m | $24.0m | $40.7m | $38.7m | $24.2m | $119.2m | $360.7m | |
| Common Stock Payments | — | — | — | — | — | — | ($38.7m) | ($24.2m) | ($119.2m) | ($360.7m) | |
| Proceeds from (Payments for) Other Financing Activities | ($8.2m) | ($4.9m) | ($1.4m) | ($11.8m) | ($5.9m) | ($2.3m) | ($7.8m) | ($4.1m) | ($31.4m) | ($14.0m) | |
| Net Other Financing Charges | — | — | — | — | — | — | ($48.6m) | ($11.6m) | ($43.4m) | ($55.0m) | |
| Net Cash Provided by (Used in) Financing Activities | $390.7m | ($208.5m) | $558.1m | $231.9m | $47.2m | $672.6m | ($42.4m) | ($85.5m) | ($550.9m) | ($536.7m) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($3.0m) | $11.2m | ($9.5m) | $11.4m | $794k | $17.7m | $25.6m | $8.0m | ($17.5m) | $18.8m | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | $25.6m | $8.0m | ($17.5m) | $18.8m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($3.0m) | $46.4m | $31.0m | $42.7m | ($6.9m) | $13.2m | ($5.1m) | $43.3m | ($78.9m) | $10.4m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($3.0m) | $166.3m | $197.3m | $240.0m | $233.1m | $246.3m | $241.2m | $284.5m | $205.6m | $216.0m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | ($5.1m) | $43.3m | ($78.9m) | $10.4m | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | $47.5m | $67.8m | $72.5m | $70.8m | $100.8m | $132.1m | $123.5m | $101.7m | |
| Income Taxes Paid, Net | — | — | — | — | $60.1m | $75.4m | $75.9m | $90.4m | $126.1m | $119.6m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.